Baseline PET as prognostic marker for Hodgkin?

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

In this issue of Blood, Akhtari et al present a retrospective analysis of baseline positron emission tomography-computed tomography (PET-CT) in Hodgkin lymphoma (HL) in relation to the prognostic significance of the metabolic tumor volume (MTV) in risk classification of early-stage HL.1 These measurements yield estimates of the total tumor burden, which has previously been demonstrated to be one of the most significant prognostic factor in HL.2 A more precise discrimination between low-risk vs high-risk HL using baseline PET-CT characteristics could be clinically useful and might inform treatment decisions.

Original languageEnglish
Pages (from-to)3-4
Number of pages2
JournalBlood
Volume131
Issue number1
DOIs
Publication statusPublished - 4 Jan 2018

Cite this

@article{9c1fb018102e435983e976cff9e8d7a3,
title = "Baseline PET as prognostic marker for Hodgkin?",
abstract = "In this issue of Blood, Akhtari et al present a retrospective analysis of baseline positron emission tomography-computed tomography (PET-CT) in Hodgkin lymphoma (HL) in relation to the prognostic significance of the metabolic tumor volume (MTV) in risk classification of early-stage HL.1 These measurements yield estimates of the total tumor burden, which has previously been demonstrated to be one of the most significant prognostic factor in HL.2 A more precise discrimination between low-risk vs high-risk HL using baseline PET-CT characteristics could be clinically useful and might inform treatment decisions.",
author = "Zijlstra, {Jos{\'e}e M.} and Ronald Boellaard",
year = "2018",
month = "1",
day = "4",
doi = "10.1182/blood-2017-11-812958",
language = "English",
volume = "131",
pages = "3--4",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

Baseline PET as prognostic marker for Hodgkin? / Zijlstra, Josée M.; Boellaard, Ronald.

In: Blood, Vol. 131, No. 1, 04.01.2018, p. 3-4.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Baseline PET as prognostic marker for Hodgkin?

AU - Zijlstra, Josée M.

AU - Boellaard, Ronald

PY - 2018/1/4

Y1 - 2018/1/4

N2 - In this issue of Blood, Akhtari et al present a retrospective analysis of baseline positron emission tomography-computed tomography (PET-CT) in Hodgkin lymphoma (HL) in relation to the prognostic significance of the metabolic tumor volume (MTV) in risk classification of early-stage HL.1 These measurements yield estimates of the total tumor burden, which has previously been demonstrated to be one of the most significant prognostic factor in HL.2 A more precise discrimination between low-risk vs high-risk HL using baseline PET-CT characteristics could be clinically useful and might inform treatment decisions.

AB - In this issue of Blood, Akhtari et al present a retrospective analysis of baseline positron emission tomography-computed tomography (PET-CT) in Hodgkin lymphoma (HL) in relation to the prognostic significance of the metabolic tumor volume (MTV) in risk classification of early-stage HL.1 These measurements yield estimates of the total tumor burden, which has previously been demonstrated to be one of the most significant prognostic factor in HL.2 A more precise discrimination between low-risk vs high-risk HL using baseline PET-CT characteristics could be clinically useful and might inform treatment decisions.

UR - http://www.scopus.com/inward/record.url?scp=85040086757&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-11-812958

DO - 10.1182/blood-2017-11-812958

M3 - Review article

VL - 131

SP - 3

EP - 4

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -